uniQure NV (FRA:UQ1) YoY EBITDA Growth : -487.15% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is uniQure NV YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. uniQure NV's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -487.15%.

uniQure NV's EBITDA per Share for the three months ended in Dec. 2023 was €-0.96.

uniQure NV YoY EBITDA Growth Historical Data

The historical data trend for uniQure NV's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

uniQure NV YoY EBITDA Growth Chart

uniQure NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

-51.51

8.28

379.80

-133.23

-123.14

uniQure NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															12.16	-71.36	-62.30	-51.13	-487.15

uniQure NV YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

uniQure NV's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-4.869	-	-2.182)	/	\| -2.182 \|
=	-123.14 %

uniQure NV's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(-0.964	-	0.249)	/	\| 0.249 \|
=	-487.15 %

uniQure NV YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of uniQure NV's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

uniQure NV (FRA:UQ1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » uniQure NV (FRA:UQ1) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

QURE:USA

Address

Paasheuvelweg 25, Amsterdam, NH, NLD, 1105 BP

Website

https://www.uniqure.com

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

uniQure NV (FRA:UQ1) Headlines

No Headlines